OpenVSafe by OpenVAERS
Search V-safe

FM7-17194-52610

2 vaccinations 6 coded responses 18 check-ins 6 free-text entries 0 call cases
Sex
Male
Age at first dose
61-65
ZIP prefix
601 / IL
Registered
2021-04-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-06
    Dose 1 — Moderna
  2. 2021-04-13
    Registered in v-safe
  3. 2021-04-13
    Survey response — day 7, dose 1
    MedDRA: Bursitis — Feeling: Good
    Free text: Olecranon bursitis within 90 minutes of shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-20
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-27
    Survey response — day 21, dose 1
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Not worsening but still have olecranon bursitis on elbow of shot arm. Occurred 90 minutes after shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-04
    Dose 2 — Moderna
  7. 2021-05-04
    Survey response — day 0, dose 2
    MedDRA: Bursitis — Feeling: Good
    Free text: Still have Olecranon Bursitis which occurred 90 minutes after first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Bursitis, Peripheral swelling — Feeling: Good · Joint pains
    Free text: Olecranon Bursitis from first shot was tingling from second shot in opposite arm. Swelling reduced overnight.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Bursitis — Feeling: Good
    Free text: Still have Olecranon Bursitis from first shot but swelling has reduced with second shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-05-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-05-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-06-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-03
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-11-02
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-05-04
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: Covid-19
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-06Moderna
22021-05-04Moderna

Free text

Release 7 — day 7, dose 1

2021-04-13

Systemic reaction (other): Olecranon bursitis within 90 minutes of shot

Release 8 — day 21, dose 1

2021-04-27

Symptoms: Not worsening but still have olecranon bursitis on elbow of shot arm. Occurred 90 minutes after shot.

Release 8 — day 0, dose 2

2021-05-04

Systemic reaction (other): Still have Olecranon Bursitis which occurred 90 minutes after first dose.

Release 8 — days 1–6 daily, dose 2

2021-05-05

Systemic reaction (other): Olecranon Bursitis from first shot was tingling from second shot in opposite arm. Swelling reduced overnight.

2021-05-06

Systemic reaction (other): Still have Olecranon Bursitis from first shot but swelling has reduced with second shot.

Release 11 — 12 months, dose 2

2022-05-04

Symptoms: Covid-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDUnevaluable event ✓ ✓ ✓
SROBursitis ✓ ✓ ✓
SROPeripheral swelling ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release